Kyung Nam Pharm Co.,Ltd. (KOSDAQ:053950)

Kyung Nam Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	48,842	62,596	59,868	82,676	88,518	140,585
Market Cap Growth	4.56%	4.56%	-27.59%	-6.60%	-37.04%	-17.15%
Enterprise Value	35,614	69,553	82,641	73,133	109,068	157,440
Last Close Price	625.00	801.00	1345.73	2144.21	3122.28	5700.02
PE Ratio	4.85	6.21	-	-	-	-
PS Ratio	0.45	1.03	1.01	1.40	1.37	1.98
PB Ratio	0.42	0.54	0.67	0.88	1.22	2.45
P/TBV Ratio	0.55	0.55	0.86	0.89	1.24	2.48
P/OCF Ratio	34.05	34.05	86.35	1155.05	-	53.76
EV/Sales Ratio	0.59	1.14	1.39	1.24	1.69	2.22
EV/EBITDA Ratio	15.23	31.16	-	-	-	38.38
EV/EBIT Ratio	-	-	-	-	61.11
EV/FCF Ratio	-7.66	-	-	-	-	-
Debt / Equity Ratio	0.33	0.33	0.57	0.35	0.55	0.72
Debt / EBITDA Ratio	16.84	16.84	-	-	-	10.09
Asset Turnover	0.37	0.37	0.39	0.45	0.51	0.71
Inventory Turnover	3.39	3.39	3.07	3.21	3.69	4.39
Quick Ratio	1.41	1.41	0.81	1.35	1.56	1.22
Current Ratio	1.68	1.68	1.03	1.70	2.16	1.49
Return on Equity (ROE)	-3.98%	-3.98%	-10.42%	-9.41%	-4.94%	-8.66%
Return on Assets (ROA)	-0.09%	-0.09%	-1.47%	-1.62%	-4.34%	1.60%
Return on Capital (ROIC)	-0.10%	-0.10%	-1.68%	-1.78%	-5.19%	2.00%
Return on Capital Employed (ROCE)	-	-	-	-	-	2.90%
Earnings Yield	20.63%	16.10%	-35.07%	-9.47%	-3.86%	-3.90%
FCF Yield	-9.52%	-7.43%	-26.94%	-3.36%	-13.16%	-30.56%
Buyback Yield / Dilution	-22.60%	-22.60%	-21.50%	-27.71%	-32.46%	-11.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.